ADX-3P is a premium triple-agonist research compound supplied as a sterile lyophilized powder for in-vitro and laboratory research applications. Each vial contains 20 mg of compound, independently confirmed by third-party analytical testing and backed by a published Certificate of Analysis.
Specifications
- Compound: ADX-3P
- Classification: Triple-agonist research compound
- Format: Lyophilized powder
- Quantity: 20 mg per vial
- Purity: Batch-specific — see Certificate of Analysis
- Appearance: White lyophilized powder
- CAS Number: Available on COA
Storage & Handling
Store sealed vials in a cool, dry place away from light and moisture. For short-term storage, keep at or below 8°C; for long-term storage, keep at -20°C. After reconstitution, store at 2–8°C. Handle in accordance with standard laboratory practice for research compounds.
Certificates of Analysis
Every batch of ADX-3P 20mg is independently tested by a third-party lab before release. All published batches for this product:
Peptide Purity 99.86% · Identity Confirmed · Fentanyl Not Detected
ILS Laboratories · COA #COA-2026-AYIYHE · Issued 07/19/2026
Verify: lab.ils-lab.com · Access Code: CW7DPCWH
Includes
1 × ADX-3P 20 mg lyophilized vial
